HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Tristar Mexico sales are "essentially halted," resulting in 47.5% second quarter sales drop.

This article was originally published in The Rose Sheet

Executive Summary

TRISTAR's MEXICO SALES ARE "ESSENTIALLY HALTED" following the devaluation of the Mexican peso in late December, the San Antonio, TX-based distributor reported April 10. Commenting on fiscal 1995 second quarter results (ended Feb. 28), Tristar Corporation noted that "the devaluation essentially halted the sales of the Company's products into Mexico," resulting in a 47.5% decline in second quarter sales to $5.9 mil., compared to $11.3 mil. in the comparable fiscal 1994 period. For the half, sales were down 33.8% to $17.4 mil. Net loss for the three months increased to $1.5 mil. compared to $971,000 in 1994.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS001529

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel